皮拉津胺与异亚胺对它们对小鼠肝脏血红蛋白生物合成途径的影响的比较

Fu-Ying Qin1, Ruizhi Gu1, Jiaojiao Zhang1

  • 1Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, 335 Sutherland Drive, Pittsburgh, PA 15261, USA.

Metabolites
|June 25, 2025
PubMed
概括

异化 (INH) 通过改变血红素合成酶来加剧病,导致有毒中间体的积累. 皮拉津胺 (PZA) 没有表现出这种影响,这表明其在病患者的禁用可能是不合理的.